2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986
Bogdanov AA, Weissleder R, Frank HW, Bogdanova AV, Nossif N, Schaffer BK, Tsai E, Papisov MI, Brady TJ
A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies.
Radiology. 1993;187(3):701-6 - PMID: 8497616
Weissleder R, Bogdanov A, Frank H, Nossiff N, Bogdanova A, Schaffer BK, Brady T, Wittenberg J
AUR Memorial Award 1993. A drug system (PDH) for interventional radiology. Synthesis, properties, and efficacy.
Invest Radiol. 1993;28(12):1083-9 - PMID: 8307710
Enochs WS, Schaffer B, Bhide PG, Nossiff N, Papisov M, Bogdanov A, Brady TJ, Weissleder R
MR imaging of slow axonal transport in vivo.
Exp Neurol. 1993;123(2):235-42 - PMID: 8405287
Shen T, Weissleder R, Papisov M, Bogdanov A, Brady TJ
Monocrystalline iron oxide nanocompounds (MION): physicochemical properties.
Magn Reson Med. 1993;29(5):599-604 - PMID: 8505895
Weissleder R, Wang YM, Papisov M, Bogdanov A, Schaffer B, Brady TJ, Wittenberg J
Polymeric contrast agents for MR imaging of adrenal glands.
J Magn Reson Imaging. 1993;3(1):93-7 - PMID: 8428107
Weissleder R, Reimer P
Iron oxide based magnetopharmaceuticals for MR imaging
Eur J Radiol. 1993;3:198-212
Schaffer BK, Linker C, Papisov M, Tsai E, Nossiff N, Shibata T, Bogdanov A, Brady TJ, Weissleder R
MION-ASF: biokinetics of an MR receptor agent.
Magn Reson Imaging. 1993;11(3):411-7 - PMID: 7685055
7